MaaT Pharma was able to accelerate development of a GMP manufacturing in a record time.
MaaT Pharmaavril 4, 2016
MaaT Pharma, which develops the first treatment using an autologous intestinal microbiota transplant is now…
MaaT Pharmafévrier 16, 2016
Important step in developing microbiome therapy for severe intestinal Dysbiosis.
MaaT Pharmajuillet 24, 2015
